Recent corporate governance scandals have brought to the fore the inherent contradictions of a capitalism dominated by financial markets. This challenging book by Michel Aglietta and Antoine Rebérioux argues that capitalism's basic premise--that companies must be managed in the sole interest of...

Do modes of management depend on company ownership? Does macroeconomic performance rely on shareholder value? The contributions collected in this book explore these questions from economic, historical and legal perspectives. They examine company ownership through the study of national...

In open and dynamic markets, only innovation can give a firm a competitive advantage and with it the superior cash flows that generate value. This book offers a new conceptual structure and applicable analytical models for evaluating a firm's innovation strategies in highly competitive...

"This second edition of the Handbook of Business-to-Business Marketing provides an updated comprehensive state-of-the-art overview of business-to-business (B2B) marketing by leading academic scholars and practitioners in the field. Each of the 34 chapters is structured to provide perspectives of...

Part I how to make M&As perform successfully: rationales and models -- 1. Basic terminology, concepts and types of M&As -- 2. Data and empirical evidence on M&A performance -- 3. Making M&As create value: an analytical model for evaluating M&As -- 4. Identifying the opportunities for successful...

1. Introduction -- 2. The intangible economy -- 3. Patent information and corporate credit ratings : an empirical study of patent valuation by credit rating agencies -- 4. IPR management and company valuation in the pharmaceutical industry : an exploratory study -- 5. IPR management, corporate...

Innovation in the Pharmaceutical Industry traces the discovery and development of drugs in Japan and the UK both historically and sociologically. It includes sixteen case studies of major pharmaceutical developments in the twentieth century, encompassing, amongst others, beta-blockers,...

This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the...

This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and...

This important book, a successor volume to European Industries, brings together a number of in-depth and authoritative studies of key European industries, providing fascinating insights into their nature and characteristics